Rand Capital Announces Fourth Quarter and Full Year 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
87
Rand Capital Announces Fourth Quarter and Full Year 2016 Results

BUFFALO, NY --(Marketwired - March 08, 2017) -

  • 2016 included sale of Gemcor, Rand's largest exit, generating $14 million in proceeds
  • Invested $5.9 million in four new portfolio companies and twelve follow-on transactions in eight portfolio companies during the year
  • Net Asset Value per share was $5.16 at December 31
  • Recently received "green light" letter from SBA in support of strategic plan to continue strong growth of Rand's capital base

Rand Capital Corporation ( NASDAQ : RAND ) ("Rand"), a venture capital company which invests in early stage and emerging growth businesses with unique product, service or technology concepts, announced its results for the quarter and full year ended December 31, 2016.

Allen F. ("Pete") Grum, President and Chief Executive Officer of Rand Capital, commented, "The 'green light' letter we recently received from the SBA authorizes us to file a formal application for a new fund. Over the past fourteen years, we have provided capital to over 50 companies through our partnership with the SBA. This new proposed fund enables us to use some of the cash we received from the Gemcor exit combined with additional leverage to create a $22.5 million fund. We will use the fund to advance our investment strategy focus on privately-held, early stage and emerging growth businesses with proven management teams."

Mr. Grum continued, "We reflect on 2016 as a year of significant progress. Early in the year with the sale of our Gemcor investment, we realized the largest exit in our history. During our 12-year holding period, Gemcor grew to be a strong provider of cash flow to Rand in the form of dividend and investment income. Accordingly, our near-term investment focus is on rebuilding cash dividends and interest to fund our ongoing operating expenses."

He added, "There are holdings in our portfolio that could represent exits over the next several years, but in the meantime, the incremental capital from the proposed new fund will enable us to expand our portfolio. Our pipeline of investment opportunities remains robust."

Fourth Quarter and Full Year 2016 Financial Highlights

  • Reported $5.16 net asset value (NAV) per share at December 31, 2016, compared with $5.35 per share at December 31, 2015; decrease due to lower net investment income and lower net realized and unrealized gains in 2016
  • Realized approximately $14 million of net pre-tax proceeds in 2016 from the sale of Gemcor, Rand's largest exit
  • For the full year, completed 16 investment transactions across 12 portfolio companies totaling $5.9 million
  • Investments made in 2016 are estimated to generate approximately $350,000 in annualized interest income
  • Portfolio fair value of $27.5 million and cash of $12.3 million at December 31, 2016

Dividend and other investment income was down approximately $553,000 in the fourth quarter of 2016, compared with the 2015 fourth quarter. Consistent with the second and third quarter results, the decline was primarily the result of the 2016 first quarter sale of Gemcor. Partially offsetting that decline was an approximately $100,000 increase in interest from portfolio companies in the fourth quarter. The increase reflects the recent debt investments. Additionally, operating expenses in the current quarter were down approximately $110,000 compared with last year's fourth quarter.

Net realized and unrealized (loss) gain on investments was down approximately $656,000 compared with the prior-year fourth quarter primarily due to the recognition of an unrealized gain on the Company's Gemcor investment in last year's fourth quarter.

Selected portfolio highlights:

  • Tilson Technology Management, Inc. ( http://www.tilsontech.com/ ) is an information technology professional services and network construction company. Having grown 500% since 2011, Tilson has been on the Inc. 5000 List of America's fastest-growing private companies for six consecutive years. They have partnered with Verizon Wireless in numerous regions, providing the know-how and resources necessary to get nodes deployed quickly in rights-of-way. Additionally, they have been licensed as a contract provider by several states for services such as electronics and telecom construction. Rand initially invested $600,000 in series B preferred shares in January 2015. Rand made additional investments of $200,000 in Series C convertible preferred shares and $200,000 in a subordinated promissory note in the third quarter of 2016.
  • PostProcess Technologies LLC ( http://postprocess.com/ ) provides innovative solutions for the post-processing of additive manufactured parts. The company is the first and only provider of automated and intelligent post-processing for 3D-printed parts. Their technology increases the consistency, throughput and productivity of the third step of 3D printing -- post-processing. Rand provided a $300,000 promissory note in the third quarter of 2016, supporting the company's product development and global growth initiatives.

Mr. Grum stated, "2016 was another robust year of investment activity. We made new investments in four diverse companies and follow-on investments in eight of our portfolio holdings, for a total of nearly $6 million. Additionally, our proposed new fund will provide us a strong capital base for further growth."

As of December 31, 2016, Rand's portfolio consisted of 33 companies. At year end, the portfolio was comprised of approximately 64% in equity investments and 36% in debt investments, compared with 85% in equity investments and 15% in debt investments at the same time last year.

Share Repurchase Program and Growth Strategy

Rand maintains a share repurchase program which has been approved by the Board of Directors through October 2017. During 2016, the Company purchased 6,550 shares; approximately 459,000 shares remain authorized for repurchase under the program.

Rand's growth strategy is to increase net asset value by capitalizing on maturing investments and leveraging those returns for further investment. Rand invests in early stage or emerging growth companies with new or unique products or services that offer competitive advantages and compelling future potential.

ABOUT RAND CAPITAL Rand Capital ( NASDAQ : RAND ) provides investors the ability to participate in venture capital opportunities through an investment in the Company's stock. Rand is a Business Development Company (BDC), and its wholly-owned subsidiary is licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its equity investments in early or expansion stage companies and generally lends to more mature companies. Rand looks for strong leadership who is bringing to market new or unique products, technologies or services that have a high potential for growth. Additional information can be found at the Company's website where it regularly posts information: http://www.randcapital.com/ .

Safe Harbor Statement This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning future net asset value growth, investment returns and opportunities as well as Rand's plans for utilizing proceeds from sales of portfolio companies when and if received. These statements involve known and unknown risks, uncertainties and other factors that could cause the actual results to differ materially from the results expressed or implied by such statements, including general economic and business conditions, conditions affecting the portfolio companies' markets, competitor responses, and market acceptance of their products and services and other factors disclosed in the Corporation's periodic reports filed with the Securities and Exchange Commission. Consequently, such forward looking statements should be regarded as the Corporation's current plans, estimates and beliefs. The Corporation assumes no obligation to update the forward-looking information contained in this release.

 
Rand Capital Corporation and Subsidiary
Consolidated Statements of Financial Position
             
    December 31,  
    2016     2015  
ASSETS            
  Investments at fair value:                
    Control investments (cost of $99,500 and $1,141,472, respectively)   $ 99,500     $ 13,916,472  
    Affiliate investments (cost of $17,589,623 and $17,663,217, respectively)     13,605,974       14,662,219  
    Non-Control/Non-affiliate investments (cost of $13,941,907 and $8,606,053, respectively)     13,795,007       8,253,709  
  Total investments, at fair value (cost of $31,631,030 and $27,410,742, respectively     27,500,481       36,832,400  
  Cash     12,280,140       5,844,795  
  Interest receivable (net of allowance: $161,000 at 12/31/16 and $122,000 at 12/31/15)     324,237       215,224  
  Deferred tax asset     1,165,164       -  
  Prepaid income taxes     -       65,228  
  Other assets     1,148,508       1,604,413  
      Total assets   $ 42,418,530     $ 44,562,060  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY (NET ASSETS)                
  Liabilities:                
  Debentures guaranteed by the SBA (net of debt issuance costs)   $ 7,827,773     $ 7,800,373  
  Profit sharing and bonus payable     1,270,052       282,000  
  Income tax payable     320,008       -  
  Deferred tax liability     -       2,361,186  
  Accounts payable and accrued expenses     324,537       238,911  
  Deferred revenue     46,797       25,930  
      Total liabilities     9,789,167       10,708,400  
                   
  Stockholders' equity (net assets):                
  Common stock, $.10 par; shares authorized 10,000,000; shares issued 6,863,034; shares outstanding of 6,321,988 at 12/31/16 and 6,328,538 at 12/31/15     686,304       686,304  
  Capital in excess of par value     10,581,789       10,581,789  
  Accumulated net investment loss     (1,577,848 )     (24,580 )
  Undistributed net realized gain on investments     27,127,054       18,262,401  
  Net unrealized (depreciation) appreciation on investments     (2,718,831 )     5,795,237  
  Treasury stock, at cost; 541,046 shares at 12/31/16 and 534,496 shares at 12/31/15     (1,469,105 )     (1,447,491 )
      Total stockholders' equity (net assets) (per share 12/31/16: $5.16, 12/31/15: $5.35)     32,629,363       33,853,660  
      Total liabilities and stockholders' equity   $ 42,418,530     $ 44,562,060  
                       
 
Rand Capital Corporation and Subsidiary
Consolidated Statements of Operations
                         
    For the Quarter Ended December 31,     For the Year Ended December 31,  
    2016     2015     2016     2015  
Investment income:                                
  Interest from portfolio companies:                                
    Control investments   $ -     $ 16,321     $ 11,828     $ 77,077  
    Affiliate investments     130,632       75,806       403,850       388,135  
    Non-Control/Non-Affiliate investments     111,448       49,363       351,475       225,897  
      Total interest from portfolio companies     242,080       141,490       767,153       691,109  
                                   
  Interest from other investments:                                
    Non-Control/Non-Affiliate investments     11,456       3,329       45,139       22,048  
      Total interest from other investments     11,456       3,329       45,139       22,048  
                                   
  Dividend and other investment income:                                
    Control investments     -       371,628       -       1,735,934  
    Affiliate investments     39,101       221,674       188,908       345,913  
    Non-Control/Non-Affiliate investments     1,013       -       4,024       -  
      Total dividend and other investment income     40,114       593,302       192,932       2,081,847  
                                   
  Fee income:                                
    Control investments     -       2,000       2,000       8,000  
    Affiliate investments     1,917       1,416       5,862       4,666  
    Non-Control/Non-Affiliate investments     5,768       4,250       18,772       16,667  
      Total fee income     7,685       7,666       26,634       29,333  
Total investment income     301,335       745,787       1,031,858       2,824,337  
                                 
Operating expenses:                                
  Salaries     155,437       149,555       621,749       598,220  
  Bonus and profit sharing     (26,607 )     122,500       1,385,052       122,500  
  Employee benefits     9,844       30,391       174,796       117,937  
  Directors' fees     42,615       40,000       184,750       129,000  
  Professional fees     101,837       74,990       339,823       202,194  
  Stockholders and office operating     52,749       65,601       227,631       222,431  
  Insurance     6,258       6,132       32,134       32,086  
  Corporate development     15,093       14,190       64,412       62,553  
  Other operating     11,944       14,357       21,414       23,330  
        369,170       517,716       3,051,761       1,510,251  
  Interest on SBA obligations     77,567       77,568       310,276       307,028  
  Bad debt expense     39,000       -       39,000       -  
  Total expenses     485,737       595,284       3,401,037       1,817,279  
Net investment (loss) income before income taxes     (184,402 )     150,503       (2,369,179 )     1,007,058  
  Income tax expense (benefit)     17,614       (98,129 )     (815,911 )     164,156  
Net investment (loss) income     (202,016 )     248,632       (1,553,268 )     842,902  
                                 
Net realized (loss) gain on sales and dispositions of investments:                                
  Control investments     31,250       -       14,620,063       -  
  Affiliate investments     (650,000 )     (300,000 )     (650,000 )     (300,000 )
  Non-Control/Non-Affiliate investments     -       (5,394 )     168,140       257,531  
  Net realized (loss) gain before income taxes     (618,750 )     (305,394 )     14,138,203       (42,469 )
  Income tax (benefit) expense     (230,793 )     (104,238 )     5,273,550       (14,496 )
  Net realized (loss) gain on sales and dispositions of investments     (387,957 )     (201,156 )     8,864,653       (27,973 )
                                 
Net change in unrealized depreciation or appreciation on investments:                                
  Control investments     -       4,100,000       (12,775,000 )     4,100,000  
  Affiliate investments     567,160       (1,986,004 )     (846,651 )     (2,429,440 )
  Non-Control/Non-Affiliate investments     -       (534,373 )     69,444       (340,801 )
  Change in unrealized depreciation or appreciation before income taxes     567,160       1,579,623       (13,552,207 )     1,329,759  
  Deferred income tax expense (benefit)     192,958       736,021       (5,038,139 )     644,469  
  Net increase (decrease) in unrealized depreciation or appreciation on investments     374,202       843,602       (8,514,068 )     685,290  
Net realized and unrealized (loss) gain on investments     (13,755 )     642,446       350,585       657,317  
Net (decrease) increase in net assets from operations   $ (215,771 )   $ 891,078     $ (1,202,683 )   $ 1,500,219  
Weighted average shares outstanding     6,321,988       6,328,538       6,325,792       6,328,538  
Basic and diluted net (decrease) increase in net assets from operations per share   $ (0.03 )   $ 0.14     $ (0.19 )   $ 0.24  
                                 

Contacts: Company: Allen F. ("Pete") Grum President and CEO Phone: 716.853.0802 Email: pgrum@randcapital.com Investors: Deborah K. Pawlowski / Karen L. Howard Kei Advisors LLC Phone: 716.843.3908 / 716.843.3942 Email: dpawlowski@keiadvisors.com / khoward@keiadvisors.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading